Status: current, Defined. Date: 31-Oct 2022. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4753841000168114 | Bevaciptin (bevacizumab 100 mg / 4 mL) injection, 4 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4753851000168111 | Bevaciptin 100 mg/4 mL injection, 4 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bevaciptin 100 mg/4 mL injection, 4 mL vial | Is a | Bevaciptin | true | Inferred relationship | Some | ||
Bevaciptin 100 mg/4 mL injection, 4 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Bevaciptin 100 mg/4 mL injection, 4 mL vial | Is a | bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | true | Inferred relationship | Some | ||
Bevaciptin 100 mg/4 mL injection, 4 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
Bevaciptin 100 mg/4 mL injection, 4 mL vial | has intended active ingredient | bevacizumab | true | Inferred relationship | Some | 1991379128 | |
Bevaciptin 100 mg/4 mL injection, 4 mL vial | has Australian BoSS | bevacizumab | true | Inferred relationship | Some | 1991379128 | |
Bevaciptin 100 mg/4 mL injection, 4 mL vial | has unit of use | vial | true | Inferred relationship | Some | 1944250705 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Bevaciptin 100 mg/4 mL injection, 4 mL vial | has TPUU | True | Bevaciptin 100 mg/4 mL injection, 4 mL vial | Inferred relationship | Some | 363829579 |
Bevaciptin 100 mg/4 mL injection, 4 mL vial | has TPUU | True | Bevaciptin 100 mg/4 mL injection, 4 mL vial | Inferred relationship | Some | 1624348656 |
Reference Sets
Trade product unit of use reference set